Furthermore, χ2 analysis between the TOP1 levels and clinicopathological characteristics of patients showed that TOP1 overexpression in ovarian cancer was associated with the International Federation of Gynecologists and Obstetricians (FIGO) stage (p < 0.044; S1 Table). This evidence concerns the gene TOP1 and ovarian carcinoma.